Structure-based design and synthesis of 1H-pyrazolo[3,4-d]pyrimidin-4-amino derivatives as Janus kinase 3 inhibitors

Add time:08/16/2019    Source:sciencedirect.com

Janus kinases (JAKs) regulate various inflammatory and immune responses and are targets for the treatment of inflammatory and immune diseases. Here we report the discovery and optimization of 1H-pyrazolo[3,4-d]pyrimidin-4-amino as covalent JAK3 inhibitors that exploit a unique cysteine (Cys909) residue in JAK3. Our optimization study gave compound 12a, which exhibited potent JAK3 inhibitory activity (IC50 of 6.2 nM) as well as excellent JAK kinase selectivity (>60-fold). In cellular assay, 12a exhibited potent immunomodulating effect on IL-2-stimulated T cell proliferation (IC50 of 9.4 μM). Further, compound 12a showed efficacy in delayed hypersensitivity assay. The data supports the further investigation of these compounds as novel JAKs inhibitors.

We also recommend Trading Suppliers and Manufacturers of tert-Butyl-4-cyano-4-(dimethyl amino) piperidine-1-carboxylate (cas 110694-59-2). Pls Click Website Link as below: cas 110694-59-2 suppliers

Prev:Bis(μ-alkoxo) bridged dinuclear CuII2 and ZnII2 complexes of an isoindol functionality based new ligand: Synthesis, structure, spectral characterization, magnetic properties and catechol oxidase activity
Next:Dynamic NMR and Theoretical Study of Hindered Internal Rotation about the C-N Bond in 4-(Phenyl) Acetyl Morpholine☆)